Source: International Congress 2016 – Features and impact of comorbidities in COPD
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Yuliia Huba (Dnipropetrovsk, Ukraine), Yuliia Huba, Lyudmyla Konopkina. The severity of anxiety in COPD patients (pts). Eur Respir J 2016; 48: Suppl. 60, 653

Member's Comments

No comment yet.

Related content which might interest you: The relation of comorbidities with the exacerbation severity in patients with COPD Source: Annual Congress 2013 –COPD mechanisms Year: 2013 Co-morbidity and hospitalization rate in patients (pts) with acute exacerbation (AE) of COPD Source: International Congress 2015 – Different data in COPD Year: 2015 Impact of comorbidities in COPD prognosys scores Source: International Congress 2016 – Features and impact of comorbidities in COPD Year: 2016 Comparing the prevalence of depression and anxiety in patients admitted with an exacerbation of COPD using two scoring systems Source: International Congress 2015 – Asthma and COPD: overlap and exacerbations Year: 2015 Renal impairment a neglected comorbidity in patients with COPD Source: International Congress 2016 – Monitoring comorbidities Year: 2016 The relationship between dyspnea and detection of depression in COPD patients (pts) Source: International Congress 2015 – Different data in COPD Year: 2015 Gender differences in hospitalized patients with acute exacerbation of COPD Source: Annual Congress 2013 –COPD biomarkers Year: 2013 COPD as undetected cause of dyspnea in patients admitted with ischaemic heart disease (IHD) Source: International Congress 2014 – COPD: points to ponder Year: 2014 Evaluation of the GOLD 2011 severity criteria across the COPD spectrum Source: Annual Congress 2013 –Predictors and triggers of asthma and COPD exacerbations Year: 2013 Outcomes in patients with COPD during a 3 year follow-up Source: International Congress 2015 – Clinical assessment and monitoring of asthma and COPD Year: 2015 Prevalence of co-morbidities with chronic obstructive pulmonary disease (COPD) in a primary care cohort Source: International Congress 2014 – Clinical presentations Year: 2014 GOLD staging and grading for predicting one-year mortality in COPD patients with severe exacerbation Source: International Congress 2016 – Biomarkers and phenotypes of COPD Year: 2016 Mortality and readmissions in patients with severe COPD. Validation of the CODEX index Source: International Congress 2015 – Best abstracts in COPD management Year: 2015 Baseline self-reported comorbidity in COPD patients referred for pulmonary rehabilitation (PR) Source: Annual Congress 2006 - COPD comorbidity Year: 2006 The serum level of surfactantproteind in patients with chronic obstructive pulmonary disease, depending on the nutrtional status Source: International Congress 2015 – Notable abstracts in exacerbations, mechanisms and biomarkers in COPD Year: 2015 COPD on anti-GERD therapy remains at higher risk for severe exacerbation Source: International Congress 2014 – COPD exacerbations Year: 2014 The impact of comorbidities on the short-term serious health outcomes in hospitalized COPD patients due to exacerbation Source: Annual Congress 2013 –COPD treatment and others Year: 2013 Alexithymia in COPD patients Source: International Congress 2015 – Clinical problems in acute and chronic lung diseases Year: 2015 Is anxiety and depression a barrier to enrolment in a study in chronic obstructive pulmonary disease (COPD)? Source: International Congress 2016 – Kaleidoscope of respiratory nursing Year: 2016 Determinants of anxiety and depression among Filipino patients with chronic obstructive pulmonary disease: A multi-center study Source: Annual Congress 2013 –Monitoring respiratory diseases: role of comorbidities and lung involvement Year: 2013